These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 9172836)
1. Pseudorabies virus infections in pigs. Role of viral proteins in virulence, pathogenesis and transmission. Mulder WA; Pol JM; Gruys E; Jacobs L; De Jong MC; Peeters BP; Kimman TG Vet Res; 1997; 28(1):1-17. PubMed ID: 9172836 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2. Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077 [TBL] [Abstract][Full Text] [Related]
3. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine. Mettenleiter TC; Klupp BG; Weiland F; Visser N J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601 [TBL] [Abstract][Full Text] [Related]
4. Pseudorabies (Aujeszky's disease) virus: state of the art. August 1993. Mettenleiter TC Acta Vet Hung; 1994; 42(2-3):153-77. PubMed ID: 7810409 [TBL] [Abstract][Full Text] [Related]
5. Assessment of replication and virulence of attenuated pseudorabies virus in swine. Newby TJ; Carter DP; Yoon KJ; Jackwood MW; Hawkins PA J Vet Sci; 2002 Jun; 3(2):61-6. PubMed ID: 12441673 [TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs. van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. Kimman TG; De Wind N; De Bruin T; de Visser Y; Voermans J Virology; 1994 Dec; 205(2):511-8. PubMed ID: 7975253 [TBL] [Abstract][Full Text] [Related]
8. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Qian P; Li XM; Jin ML; Peng GQ; Chen HC Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769 [TBL] [Abstract][Full Text] [Related]
9. Aujeszky's disease virus strains with peculiar features. Motovski AD Acta Vet Hung; 1994; 42(2-3):213-6. PubMed ID: 7810415 [TBL] [Abstract][Full Text] [Related]
10. Glycoprotein I of pseudorabies virus (Aujeszky's disease virus) determines virulence and facilitates penetration of the virus into the central nervous system of pigs. Jacobs L; Mulder WA; Priem J; Pol JM; Kimman TG Acta Vet Hung; 1994; 42(2-3):289-300. PubMed ID: 7810422 [TBL] [Abstract][Full Text] [Related]
11. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure. Kelling CL; Staudinger WL; Rhodes MB Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139 [TBL] [Abstract][Full Text] [Related]
12. Ribonucleotide reductase-deficient mutants of pseudorabies virus are avirulent for pigs and induce partial protective immunity. de Wind N; Berns A; Gielkens A; Kimman T J Gen Virol; 1993 Mar; 74 ( Pt 3)():351-9. PubMed ID: 8383170 [TBL] [Abstract][Full Text] [Related]
13. Transmission of two pseudorabies virus strains that differ in virulence and virus excretion in groups of vaccinated pigs. Bouma A; De Jong MC; Kimman TG Am J Vet Res; 1996 Jan; 57(1):43-7. PubMed ID: 8720236 [TBL] [Abstract][Full Text] [Related]
14. Replication and pathogenicity after intranasal and intracranial inoculation of swine with a recombinant pseudorabies virus containing a deletion at the UL/IR junction. Dean HJ; Miller JM; Ackermann MR; Gao XY; Anderson LL; Jacobson CD; Cheung AK Virology; 1996 Sep; 223(1):19-28. PubMed ID: 8806536 [TBL] [Abstract][Full Text] [Related]
15. Deletion of glycoprotein gM of pseudorabies virus results in attenuation for the natural host. Dijkstra JM; Gerdts V; Klupp BG; Mettenleiter TC J Gen Virol; 1997 Sep; 78 ( Pt 9)():2147-51. PubMed ID: 9292000 [TBL] [Abstract][Full Text] [Related]
16. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV. Kit S; Kit M; McConnell S; Lawhorn B Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426 [TBL] [Abstract][Full Text] [Related]
17. Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins. Dory D; Torché AM; Béven V; Blanchard P; Loizel C; Cariolet R; Jestin A Vaccine; 2005 May; 23(26):3483-91. PubMed ID: 15837372 [TBL] [Abstract][Full Text] [Related]
18. A live gI/gE-deleted pseudorabies virus (PRV) protects weaned piglets against lethal variant PRV challenge. Yin Y; Xu Z; Liu X; Li P; Yang F; Zhao J; Fan Y; Sun X; Zhu L Virus Genes; 2017 Aug; 53(4):565-572. PubMed ID: 28417300 [TBL] [Abstract][Full Text] [Related]
19. Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge. Vilnis A; Sussman MD; Thacker BJ; Senn M; Maes RK Vet Microbiol; 1998 May; 62(2):81-96. PubMed ID: 9695282 [TBL] [Abstract][Full Text] [Related]
20. The influence of recombination on the genetic stability of pseudorabies vaccine virus. Visser N Dev Biol Stand; 1995; 84():97-104. PubMed ID: 7796973 [No Abstract] [Full Text] [Related] [Next] [New Search]